https://investingnews.com/daily/life-science-investing/biotech-investing/oncomed-early-clinical-data-anti-tigit-antibody/
OncoMed Announces Early Clinical Data for anti-TIGIT Antibody | INN
Jan 3, 2026 - OncoMed Pharmaceuticals (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today...
early clinicaloncomedannouncesdataanti